Page last updated: 2024-09-03

ym 022 and Inflammatory Bowel Diseases

ym 022 has been researched along with Inflammatory Bowel Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Attoub, S; Bado, A; Barbier, M; Cherbut, C; Galmiche, JP; Joubert, M; Laboisse, C	1

Other Studies

1 other study(ies) available for ym 022 and Inflammatory Bowel Diseases

Article	Year
Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist. Life sciences, 2001, Jun-22, Volume: 69, Issue:5 Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Benzodiazepines; Colitis; Disease Models, Animal; Ethanolamines; Hormone Antagonists; Inflammatory Bowel Diseases; Leptin; Male; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Adrenergic, beta-3; Receptors, Cholecystokinin; Severity of Illness Index	2001

Article

Year

Proinflammatory role of leptin in experimental colitis in rats benefit of cholecystokinin-B antagonist and beta3-agonist.

Life sciences, 2001, Jun-22, Volume: 69, Issue:5

Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Benzodiazepines; Colitis; Disease Models, Animal; Ethanolamines; Hormone Antagonists; Inflammatory Bowel Diseases; Leptin; Male; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Adrenergic, beta-3; Receptors, Cholecystokinin; Severity of Illness Index

2001